From each FDA label

Do GLP-1s change your sense of taste?

Rybelsus/Ozempic tablets, Trulicity, Victoza and Byetta list it only among reports after approval, without a rate.

Read from each manufacturer's FDA label on DailyMed. The newest revision saying anything on this is Aug 28, 2026.

Word for word

What each label says about taste changes

Sentences from each label's warnings and side effect sections. Only cross-references are removed.

Wegovy

  • In clinical trials in adults for weight reduction, 1.7% of Wegovy-treated patients and 0.5% of placebo-treated patients reported dysgeusia.

Label revised Jun 18, 2026. DailyMed

Ozempic

  • Other adverse reactions with a frequency of >0.4% were associated with Ozempic include fatigue, dysgeusia and dizziness.

Label revised Jun 1, 2026. DailyMed

Zepbound

  • In a pool of Study 1 and 2, dysgeusia was reported by 0.4% of Zepbound-treated patients and no placebo-treated patients.

Label revised Aug 28, 2026. DailyMed

Mounjaro

  • In the pool of placebo-controlled clinical trials in adults, dysgeusia was reported by 0.1% of Mounjaro-treated patients and 0% of placebo-treated patients.

Label revised Aug 27, 2026. DailyMed

Foundayo

  • In a pool of Trials 1 and 2, dysgeusia was reported in 0.9% of Foundayo-treated patients and 0.3% of placebo-treated patients.

Label revised Jul 29, 2026. DailyMed

Saxenda

  • Events of asthenia, fatigue, malaise, dysgeusia and dizziness were mainly reported within the first 12 weeks of treatment with Saxenda and were often co-reported with gastrointestinal events such as nausea, vomiting, and diarrhea.

Label revised Feb 25, 2026. DailyMed

Rybelsus and Ozempic tablets, Trulicity, Victoza, Byetta: listed only among reports after approval, which come with no rate because nobody knows how many people took the medicine.

Not from trials

Reports to FDA about taste changes

Counts of voluntary reports from patients and doctors. They cannot show that a medicine caused anything and cannot give a rate, and a brand used by more people draws more reports.

MedicineReports namingAll reports on it
ByettaChanged sense of taste: 62652,087
Rybelsus and Ozempic tabletsChanged sense of taste: 907,758
FoundayoChanged sense of taste: 113,050

Counted through openFDA from FDA's Adverse Event Reporting System, refreshed weekly. One report can name several terms.

Updated automatically

Latest FDA label updates

Written from each source's own record as it changes. Every change on GLPcompare

Questions

Taste changes on a GLP-1: common questions

Does Wegovy change your sense of taste?

Its FDA label: In clinical trials in adults for weight reduction, 1.7% of Wegovy-treated patients and 0.5% of placebo-treated patients reported dysgeusia.

Does Ozempic change your sense of taste?

Its FDA label: Other adverse reactions with a frequency of >0.4% were associated with Ozempic include fatigue, dysgeusia and dizziness.

Does Zepbound change your sense of taste?

Its FDA label: In a pool of Study 1 and 2, dysgeusia was reported by 0.4% of Zepbound-treated patients and no placebo-treated patients.

Does Mounjaro change your sense of taste?

Its FDA label: In the pool of placebo-controlled clinical trials in adults, dysgeusia was reported by 0.1% of Mounjaro-treated patients and 0% of placebo-treated patients.

Does Foundayo change your sense of taste?

Its FDA label: In a pool of Trials 1 and 2, dysgeusia was reported in 0.9% of Foundayo-treated patients and 0.3% of placebo-treated patients.

Does Saxenda change your sense of taste?

Its FDA label: Events of asthenia, fatigue, malaise, dysgeusia and dizziness were mainly reported within the first 12 weeks of treatment with Saxenda and were often co-reported with gastrointestinal events such as nausea, vomiting, and diarrhea.

Other side effects

Trial rates describe groups, not what one person will feel. Talk to your clinician before starting, stopping or changing a medicine.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.